Phase 2 Metastatic Castration-Resistant Prostate Cancer (mCRPC) trials recruiting now
All Metastatic Castration-Resistant Prostate Cancer (mCRPC) trials, every phase
8
Phase 2 recruiting
Other phases for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2 Metastatic Castration-Resistant Prostate Cancer (mCRPC) trials
- A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC
- A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)
- Cannabidiol for Pain Relief of Patients With End-stage mCRPC
- Combination Study of Antibiotics With Enzalutamide (PROMIZE)
- Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
- Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
- REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
Common questions
What does Phase 2 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.